Kimia Biosciences
Business Connect Magazine
Business Connect- A magazine of new era for the business community! We Aspire to Inspire! Connecting the Business world!
Leading the Way in Pharmaceutical Innovation and Growth
Business Connect is a platform renowned for its impeccable monthly editions comprising some of the great success stories around the world. Here again, we are back with our exclusive edition, “Sales & Marketing Leader Of The Year-2023”. And to make this edition successful, our editorial team had an interesting and joyful virtual session with the leadership panel of Kimia Biosciences, a leading venture in the Pharmaceutical arena.
The leadership panel of the company and the AGM of Sales & Marketing, Ms. Ruchita Mishra, shared numerous lesser-known facts about the company and also shed some light on her overall entrepreneurial journey so far. We truly hope and desire that this fascinating read will add some extra value to the lives of our global leadership and will surely encourage them to break the barriers and chase their dreams.
领英推荐
COMPANY PREFACE
India’s pharmaceutical and life sciences sector has played a vital role in improving health outcomes at home and abroad. The country’s strength in manufacturing vaccines, and generic drugs, and its recent foray into biopharmaceuticals have all contributed to this success. The pharmaceutical industry presents a vast opportunity, accounting for two-thirds of the global pharmaceutical market.
India’s position as an innovation powerhouse is supported by its strong domestic industry, advanced technical capabilities, and impressive scientific expertise. The company is committed to continually improving product and service quality standards and has been a major contributor to the industry’s success.
With a diverse skill set in Marketing, Ms. Ruchita possesses the qualifications of an IT Engineer and has a Master’s in Business and Management from the University of Strathclyde, Scotland. She also has expertise in Sales, Business Development, New Product Development, Strategy Planning, Brand Building & Management, and Client Relationship Management.
Kimia Biosciences?manufactures bulk drugs for a range of high-potential therapeutic segments. The company has ambitious plans for growth, which include expanding its infrastructure and investing in contract manufacturing services (CMS). In pursuit of these goals, Kimia has allocated significant funds over the next two years to solidify its position as a major player in both Indian and international markets.
Read Full Article Here: https://businessconnectindia.in/kimia-biosciences/